Advertisement

An International Perspective on Improving the Quality and Potential of Behavioral Clinical Trials

  • Simon L. BaconEmail author
  • Kim L. Lavoie
  • Gregory Ninot
  • Susan Czajkowski
  • Kenneth E. Freedland
  • Susan Michie
  • Paul Montgomery
  • Lynda H. Powell
  • Bonnie Spring
  • for the International Behavioural Trials Network (IBTN)
Physical Activity (D Warburton, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Physical Activity

Abstract

Healthy behaviors (e.g., eating a healthy diet, engaging in regular physical activity, smoking cessation) are associated with a reduction in the incidence and mortality of chronic non-communicable diseases (NCDs), including cardiovascular disease. There have been many examples of health behavior interventions leading to improvements in NCDs and their risk factors, such as hypertension. However, despite their potential benefits, the uptake of existing behavioral interventions has been limited. Among many barriers to implementation of behavioral treatments are concerns about methodological inadequacies. The current manuscript discusses recent advances in frameworks for the development of interventions, the reporting of trials and their protocols, and areas which need further work. The goal of this article is to increase awareness and encourage further debate about how best to promote high-quality behavioral intervention research.

Keywords

Behavioral trials Clinical trials Control groups Methodology Outcomes Treatment fidelity International Behavioural Trials Network 

Notes

Acknowledgments

The members of the IBTN (IBTNetwork.org) would like to thank the Canadian Institutes of Health Research—MPE 132280 for the initial funding for the network and Mr. Guillaume Lacoste for overseeing the coordination of the network. In addition, Drs. Bacon and Lavoie both received salary support from the Fonds de Recherche du Quebec—Sante and the Canadian Institutes for Health Research which aid in the maintenance of the network.

Founding Members of the IBTN

Name

Institution

Position

Simon Bacon, PhD

Concordia University and Hôpital du Sacré-Coeur de Montréal

Professor of Exercise Science and Co-Director of the Montreal Behavioural Medicine Centre

Kim Lavoie, PhD

Université du Québec à Montréal and Hôpital du Sacré-Coeur de Montréal

Professor of Psychology and Co-Director of the Montreal Behavioural Medicine Centre

Gregory Ninot, PhD

University of Montpellier

Director of the Epsylon Laboratory

Jean Bourbeau, MD

Montreal Chest Institute and McGill University

Director of the Respiratory Epidemiology and Clinical Research Unit (RECRU)

Isabelle Boutron, MD

University Paris Descartes and INSERM U738

Professor of Clinical Epidemiology

Tim Caulfield, PhD

University of Alberta

Canada Research Chair in Health Law and Policy

Susan Czajkowski, PhD

National Heart, Lung and Blood Institute, NIH

Program Director

Karina Davidson, PhD

Columbia University

Director of the Center for Behavioral and Cardiovascular Health

Kenneth Freedland, PhD

Washington University School of Medicine

Professor of Psychiatry and Psychology

Gaston Godin, PhD

Laval University

Professor Emeritus

Susan Michie, PhD

University College London

Director of the Health Psychology Research Group

David Moher, PhD

Ottawa Hospital Research Institute

University of Ottawa Research Chair

Paul Montgomery, DPhil

Oxford University

Professor of Psycho-Social Intervention

Lynda Powell, PhD

Rush University Medical Center

Charles J. and Margaret Roberts Professor of Preventive Medicine

Lise Rochaix, PhD

Université Paris 1 Panthéon-Sorbonne

Professeur des Universités en Sciences économiques

David Secko, PhD

Concordia University

Team Leader of the Concordia Science Journalism Project

Stan Shapiro, PhD

McGill University

Professor of Epidemiology and Biostatistics

Bonnie Spring, PhD

Northwestern University

Director of the Center for Behavior and Health

Compliance with Ethics Guidelines

Conflict of Interest

Kenneth Freedland, Kim Lavoie, Susan Czajkowski, Susan Michie, Lynda H. Powell, Gregory Ninot, and Bonnie Spring have no conflicts of interest. Simon Bacon received a grant from the Canadian Institutes of Health Research (CIHR) and the Fonds de Recherche du Quebec—Sante. Paul Montgomery received support from CIHR.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.PubMedCrossRefGoogle Scholar
  2. 2.
    Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.PubMedCrossRefGoogle Scholar
  3. 3.
    Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990? 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.PubMedCrossRefGoogle Scholar
  4. 4.
    Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Mozaffarian D, Wilson PWF, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117(23):3031–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57(16):1690–6.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Spring B, Moller AC, Colangelo LA, et al. Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation. 2014;130(1):10–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease. JAMA. 2003;290(1):86–97.PubMedCrossRefGoogle Scholar
  10. 10.
    Moullec G, Laurin C, Lavoie KL, Ninot G. Effects of pulmonary rehabilitation on quality of life in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2011;17(2):62–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn. 2007;3(2):101–29.PubMedCrossRefGoogle Scholar
  12. 12.
    Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Langford DJ, Lee K, Miaskowski C. Sleep disturbance interventions in oncology patients and family caregivers: a comprehensive review and meta-analysis. Sleep Med Rev. 2012;16(5):397–414.PubMedCrossRefGoogle Scholar
  14. 14.
    Gage JD, Everett KD, Bullock L. A review of research literature addressing male partners and smoking during pregnancy. J Obstet Gynecol Neonatal Nurs. 2007;36(6):574–80.PubMedCrossRefGoogle Scholar
  15. 15.
    Turner L, Shamseer L, Altman D, Schulz K, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1(1):60.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.••
    Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Brit Med J. 2010;340(340):698–702. This paper provides the details of the elements of the CONSORT Statement which are key to reporting randomised clinical trials.Google Scholar
  17. 17.
    Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Int Med. 2008;148(4):295–309.PubMedCrossRefGoogle Scholar
  18. 18.
    Montgomery P, Grant S, Hopewell S, et al. Protocol for CONSORT-SPI: an extension for social and psychological interventions. Implement Sci. 2013;8(1):99.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Brit Med J. 2013;346:e7586.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.•
    Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95. The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions.PubMedCrossRefGoogle Scholar
  21. 21.
    Michie S, van Stralen M, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Hoffmann TC, Glasziou PP, Boutron I, et al. (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Brit Med J. 348.Google Scholar
  23. 23.
    Bhatt A. Evolution of clinical research: a history before and beyond James Lind. Perspect Clin Res. 2010;1(1):6–10.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Greenwald P, Cullen JW. The new emphasis in cancer control. J Natl Cancer Inst. 1985;74(3):543–51.PubMedGoogle Scholar
  25. 25.••
    Czajkowski SM, Powell LH, Adler N, et al. From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 2014. This paper outlines the key elements of the ORBIT behavioural intervention development model which provides a usable framework for intervention development and testing.Google Scholar
  26. 26.
    Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new medical research council guidance. Brit Med J. 2008;337:a1655.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Wade DT. Outcome measures for clinical rehabilitation trials: impairment, function, quality of life, or value? Am J Phys Med Rehabil. 2003;82(10):S26–31.PubMedCrossRefGoogle Scholar
  28. 28.
    Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin Psychol Rev. 1991;11(3):247–66.CrossRefGoogle Scholar
  29. 29.
    Montgomery P, Underhill K, Gardner F, Operario D, Mayo-Wilson E. The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses. J Clin Epidemiol. 2013;66(8):874–82.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Guydish J, Campbell BK, Manuel JK, et al. Does treatment fidelity predict client outcomes in 12-Step Facilitation for stimulant abuse? Drug Alcohol Depend. 2014;134:330–6.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Perepletchikova F, Treat TA, Kazdin AE. Treatment integrity in psychotherapy research: analysis of the studies and examination of the associated factors. J Consult Clin Psychol. 2007;75(6):829–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Simon L. Bacon
    • 1
    • 2
    • 3
    Email author
  • Kim L. Lavoie
    • 1
    • 4
  • Gregory Ninot
    • 5
    • 6
  • Susan Czajkowski
    • 7
  • Kenneth E. Freedland
    • 8
  • Susan Michie
    • 9
  • Paul Montgomery
    • 10
  • Lynda H. Powell
    • 11
  • Bonnie Spring
    • 12
  • for the International Behavioural Trials Network (IBTN)
  1. 1.Montreal Behavioural Medicine CentreHôpital du Sacré-Cœur de MontréalMontrealCanada
  2. 2.Centre de réadaptation Jean-Jacques-GauthierHôpital du Sacré-Cœur de MontréalMontrealCanada
  3. 3.Department of Exercise ScienceConcordia UniversityMontrealCanada
  4. 4.Department of PsychologyUniversité du Québec à MontréalMontrealCanada
  5. 5.Epsylon Research UnitUniversity of MontpellierMontpellierFrance
  6. 6.iCEPSUniversity of MontpellierMontpellierFrance
  7. 7.National Heart, Lung and Blood InstituteNational Institutes of HealthBethesdaUSA
  8. 8.Department of PsychiatryWashington University School of MedicineSt. LouisUSA
  9. 9.Department of Clinical, Educational and Health PsychologyUniversity College LondonLondonUK
  10. 10.Centre for Evidence-Based InterventionOxford UniversityOxfordUK
  11. 11.Department of Preventive MedicineRush University Medical CenterChicagoUSA
  12. 12.Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations